Document is current
Any future updates will be listed below
-
Authors
Martin, Erin L. https://orcid.org/0000-0001-8145-4933
Baker, Nathaniel L.
Neelon, Brian
Saladin, Michael E.
Gray, Kevin M.
Watson, Zoe
McRae-Clark, Aimee L.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (T32-DA007288)
National Institute on Drug Abuse (U54-DA016511)
National Institute on Drug Abuse (U54-DA016511)
National Center for Advancing Translational Sciences (UL1-TR001450)
- License Information
-
More Information
Article History
Received: 11 March 2026
Accepted: 1 July 2026
First Online: 10 July 2026
Declarations
Ethics approval and consent to participate: Study procedures were approved by the MUSC Institutional Review Board and were conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.
Competing interests: KMG has provided consultation to Achieve Life Sciences, Indivior, and Jazz Pharmaceuticals, and he has received research support from Aelis Farma. ALM-C has provided consultation to Indivior and has received research support from PleoPharma. The other authors report no conflicts of interest.
